Search for: "Watson Pharmaceuticals"
Results 301 - 320
of 359
Sorted by Relevance
|
Sort by Date
16 Jul 2012, 1:32 pm
Watson v. [read post]
19 Jan 2011, 3:23 pm
In a study using 2006 Irish Census data, Dorothy Watson and Peter Lunn operationalise some of these ideas. [read post]
14 Jul 2010, 7:53 am
Watson Pharmaceuticals, Inc., 211 F.3d 21 (2d Cir. 2000). [read post]
26 Mar 2010, 12:33 pm
That the Board cites the commission of Towers Watson to do such work, an unproductive and irrelevant use of the shareholders’ money, confirms my assertion. [read post]
12 Apr 2011, 10:07 pm
Infringement proceedings by the European Commission against Italy (Kluwer Patent Blog) India approves free access to important portions of the Traditional Knowledge Digital Library (TK Community) (Spicy IP) USPTO proposes changes to PTA and PTE provisions (Patent Docs) US: FDA issues warning letter for failure to submit animal study reports in an IDE (FDA Law Blog) US: AMP v USPTO – oral argument at the Federal Circuit (Patent Docs) US: A historical perspective on the gene patent controversy… [read post]
15 Sep 2010, 2:40 am
(Afro-IP) Africa: Giving consumers power in the battle against counterfeits (Afro-IP) Australia: Review Four Corners’ ‘Body Corporate’ program on gene patenting (Patentology) India: Roche and Novartis, finally, manage to defend their patents in oppositions filed by Cipla (Spicy IP) South Africa: San people push for new legislation – demand protection for indigenous knowledge and IP including medicinal remedies derived from plants including Hoodia (Afro-IP) US: PHOSITA:… [read post]
15 Feb 2011, 4:57 pm
WorkCover NSW’s General Manager of Work Health and Safety Division John Watson said safety for workers should be the highest priority for employers, particularly in workplaces where heavy machinery is being handled. [read post]
1 Dec 2011, 3:58 am
Ranbaxy's Lipitor-copy goes on sale 1 Dec 2011, but the impact on consumers is a bit more complicated than one might think.For example, Watson Pharmaceuticals is selling a Lipitor copy under an agreement made with patentee Pfizer (thus, an authorized generic). [read post]
5 May 2014, 8:28 am
This prompted an Actavis subsidiary, Watson Laboratories, Inc., to file suit against the U.S. [read post]
19 Feb 2024, 12:55 pm
Watson, 188 F. [read post]
10 Nov 2010, 1:11 am
Roche (Filewrapper) (Property, intangible) US: Senator Sanders letter to FDA: U.S. needs an ethical pathway for biological products (KEI) (FDA Law Blog) US: Daiichi Sankyo seeks review and correction of patent term adjustment calculation for patent relating to ‘nucleoside and oligonucleotide analogues’ (Patent Docs) US: CAFC in Abraxis v Navinta: remembering Stanford/Roche (IPBiz) Products Alimta (Pemetrexed) – US: Eli Lilly files patent infringement complaint against Teva in… [read post]
26 Sep 2007, 1:04 pm
First, gabapentin must be highly purified before being formulated into the pharmaceutical preparation. [read post]
27 Apr 2017, 1:30 am
Come prepared for a lively, interactive workshop.World Café Hosts:Dayna Matthew, University of Colorado Law SchoolCharity Scott, Georgia State University College of LawSidney Watson, Saint Louis University School of LawInvited Discussants and Participants:Rodney Adams, Virginia Commonwealth University School of Health AdministrationChristina Juris Bennett, University of Oklahoma College of LawAmy Campbell, University of Memphis Cecil C. [read post]
8 Feb 2017, 3:09 am
Watson Laboratories, Inc., No. 16-493 (pre-AIA, do secret sales count as prior art?) [read post]
16 Jan 2017, 5:44 pm
Watson Laboratories, Inc., No. 16-493 (pre-AIA, do secret sales count as prior art?) [read post]
25 Aug 2014, 8:57 am
Some district courts have permitted originators to maintain declaratory actions against a generic manufacturer (see e.g. the Second Circuit in Cephalon v Watson (2009)). [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
15 Nov 2013, 11:34 am
Watson v. [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution … [read post]
31 Oct 2008, 8:30 pm
Indirect purchasers of Cipro and various advocacy groups appealed a summary judgment of federal antitrust claims and dismissal of their state antitrust claims against patent holders and brand-name manufacturers, Bayer AG and Bayer Corp. and the generic manufacturers, Barr Labs, Hoechst Marion Roussel, The Rugby Group, and Watson Pharmaceuticals. [read post]
